十一月 2025
- Home
- Cytokinetics
十一月 2025的Cytokinetics市场份额分析
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.
Cytokinetics(包含公司地区分支机构)
查看更多网站流量和参与度信息- cytokinetics.com
Cytokinetics收入截至 十一月 2025为 50M - 75M
Cytokinetics主要域名产生的收入
3 年中Cytokinetics主要域名的收入
Cytokinetics主要域名的收入
Cytokinetics热门域名的总访问量
了解Cytokinetics市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Cytokinetics热门域名的平均访问时长
分析Cytokinetics参与度指标。
过去 3 个月的平均访问时长
子公司明细
Cytokinetics热门域名的平均页面浏览量
了解Cytokinetics如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Cytokinetics 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Cytokinetics launches CHMP opinion for myqorzo.Cytokinetics announces positive CHMP opinion for myqorzo(r)(aficamten) in the treatment of obstructive Hypertrophic Cardiomyopathy.
十二月 13, 2025阅读更多
新闻Cytokinetics has issues with deadline in Class Action lawsuit.CYTOKINETICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of lead plaintiff deadline in Class Action lawsuit against Cytokinetics, Incorporated - CYTK.
九月 26, 2025阅读更多
新闻Cytokinetics attended event Stifel 2025 Virtual Cardiometabolic Forum on Sep 23rd '25.SOUTH SAN FRANCISCO, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) - Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that members of the Company's management team are scheduled to present a corporate update at the Stifel 2025 Virtual Cardiometabolic Forum on Tuesday, September 30, 2025 at 10:00 AM Eastern Time.
九月 23, 2025阅读更多
查看 Cytokinetics 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。